Iterum Therapeutics plc Annual Income Tax Expense (Benefit) in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Iterum Therapeutics plc quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2016 to 2023.
  • Iterum Therapeutics plc Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $31K, a 83.4% decline year-over-year.
  • Iterum Therapeutics plc Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $382K.
  • Iterum Therapeutics plc annual Income Tax Expense (Benefit) for 2023 was $613K, a 104% increase from 2022.
  • Iterum Therapeutics plc annual Income Tax Expense (Benefit) for 2022 was $301K, a 57.3% decline from 2021.
  • Iterum Therapeutics plc annual Income Tax Expense (Benefit) for 2021 was $705K, a 5.11% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $613K +$312K +104% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $301K -$404K -57.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $705K -$38K -5.11% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-28
2020 $743K +$299K +67.3% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-16
2019 $444K -$28K -5.93% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-28
2018 $472K +$28K +6.31% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-12
2017 $444K +$331K +293% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-12
2016 $113K Jan 1, 2016 Dec 31, 2016 10-K 2019-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.